DekaBank Deutsche Girozentrale’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-20,650
Closed -$3.15M 1425
2021
Q1
$3.15M Sell
20,650
-18,450
-47% -$2.51M 0.01% 594
2020
Q4
$4.74M Sell
39,100
-3,350
-8% -$375K 0.02% 471
2020
Q3
$4.11M Buy
+42,450
New +$4.33M 0.02% 448
2019
Q4
Sell
-42,600
Closed -$4.19M 1255
2019
Q3
$4.19M Sell
42,600
-79,200
-65% -$7.87M 0.03% 384
2019
Q2
$11.7M Buy
121,800
+96,700
+385% +$9.23M 0.06% 303
2019
Q1
$2.64M Sell
25,100
-4,800
-16% -$502K 0.02% 546
2018
Q4
$2.68M Buy
29,900
+4,800
+19% +$486K 0.02% 480
2018
Q3
$2.64M Sell
25,100
-650
-3% -$67.7K 0.02% 559
2018
Q2
$2.39M Hold
25,750
0.02% 543
2018
Q1
$2.14M Sell
25,750
-3,000
-10% -$267K 0.01% 557
2017
Q4
$2.16M Hold
28,750
0.02% 528
2017
Q3
$2.16M Hold
28,750
0.02% 535
2017
Q2
$2.16M Hold
28,750
0.02% 530
2017
Q1
$1.88M Buy
+28,750
New +$1.69M 0.02% 497
2016
Q3
Sell
-28,800
Closed -$1.2M 1043
2016
Q2
$1.2M Buy
28,800
+1,400
+5% +$64.5K 0.01% 526
2016
Q1
$1.17M Buy
+27,400
New +$1.16M 0.01% 531

Other funds holding PRAH

DekaBank Deutsche Girozentrale's PRAH Position: Q2 2021 in Review

DekaBank Deutsche Girozentrale sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2021, closing a stake of 20,650 shares — an estimated $3.15M sold.

DekaBank Deutsche Girozentrale first reported a position in PRAH in Q1 2016 and held it in 16 quarters. The position peaked at $11.7M in Q2 2019. 317 funds tracked by Wall St. Rank hold PRAH as of Q2 2021.

  • DekaBank Deutsche Girozentrale reported no remaining PRA Health Sciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 20,650 PRA Health Sciences, Inc. shares in Q2 2021, an estimated $3.15M.
  • DekaBank Deutsche Girozentrale first reported a position in PRA Health Sciences, Inc. in Q1 2016 and held it in 16 quarters.
  • DekaBank Deutsche Girozentrale's PRA Health Sciences, Inc. position peaked at $11.7M in Q2 2019.
  • 317 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2021.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2021, filed 5 Aug 2021.